These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 4567564
1. Oral contraceptives and thromboembolism. Med Lett Drugs Ther; 1972 Aug 18; 14(17):61-2. PubMed ID: 4567564 [No Abstract] [Full Text] [Related]
2. Oestrogen content of oral contraceptives and thromboembolism. McQueen EG. N Z Med J; 1970 May 18; 71(456):317. PubMed ID: 5270982 [No Abstract] [Full Text] [Related]
3. Estrogens and thromboembolic diseases. Present conception of a controversial issue. Zador G. Acta Obstet Gynecol Scand Suppl; 1976 May 18; 54():13-28. PubMed ID: 788441 [No Abstract] [Full Text] [Related]
4. Combined oral contraceptives. A statement by the committee on safety of drugs. Br Med J; 1970 Apr 25; 2(5703):231-2. PubMed ID: 5443411 [No Abstract] [Full Text] [Related]
6. [The search for new ways with low dose contraceptives. II]. Tóth F, Gimes R, Horn B, Kerényi T. Z Arztl Fortbild (Jena); 1972 Oct 15; 66(20):1021-5. PubMed ID: 4651027 [No Abstract] [Full Text] [Related]
7. Oral contraceptives. Med Lett Drugs Ther; 1968 Aug 23; 10(17):66-8. PubMed ID: 5730144 [No Abstract] [Full Text] [Related]
8. Monitoring side effects of contraceptives. Hill AB. Acta Endocrinol Suppl (Copenh); 1974 Aug 23; 185():279-95. PubMed ID: 4593796 [No Abstract] [Full Text] [Related]
9. Oral contraceptives and thromboembolism. N Z Med J; 1970 May 23; 71(456):305. PubMed ID: 5270981 [No Abstract] [Full Text] [Related]
10. Thromboembolic disease in women on sequential contraceptives with unopposed ethinyl estradiol. Wait RB, Sturtevant FM, Shook JG. J Reprod Med; 1972 Aug 23; 9(2):41-4. PubMed ID: 5050401 [No Abstract] [Full Text] [Related]
11. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)]. Schmidt-Elmendorff HW. MMW Munch Med Wochenschr; 1975 Feb 28; 117(9):345-8. PubMed ID: 804642 [Abstract] [Full Text] [Related]
12. Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives. Drill VA, Calhoun DW. JAMA; 1972 Jan 31; 219(5):593-6. PubMed ID: 5066804 [No Abstract] [Full Text] [Related]
14. Safety and efficacy of an extended-regimen oral contraception utilizing low-dose ethinyl estradiol. Anderson FD. Contraception; 2006 Oct 31; 74(4):355. PubMed ID: 16982247 [No Abstract] [Full Text] [Related]
15. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Inman WH, Vessey MP, Westerholm B, Engelund A. Br Med J; 1970 Apr 25; 2(5703):203-9. PubMed ID: 5443406 [Abstract] [Full Text] [Related]
16. [Liver cell tumor induction by oral contraceptives]. Gräf KJ, Meyer zum Büschenfelde KH. Dtsch Med Wochenschr; 1980 Jan 11; 105(2):61-5. PubMed ID: 6766098 [No Abstract] [Full Text] [Related]
17. Changing oral contraceptives. Br Med J; 1969 Dec 27; 4(5686):789-91. PubMed ID: 5359946 [No Abstract] [Full Text] [Related]
18. An analysis of the reported association of oral contraceptives to thromboembolic disease. Odell WD. West J Med; 1975 Jan 27; 122(1):26-33. PubMed ID: 1089003 [No Abstract] [Full Text] [Related]
19. [4 cases of hyperplastic gingivitis during estroprogestational contraception]. Muller M, Aloi JC, Namur E. Bull Fed Soc Gynecol Obstet Lang Fr; 1969 Jan 27; 21(3):329-31. PubMed ID: 5400375 [No Abstract] [Full Text] [Related]
20. Effect of selected estrogens and progestins on human chromosomes in vitro. Stenchever MA, Jarvis JA, Kreger NK. Obstet Gynecol; 1969 Aug 27; 34(2):249-51. PubMed ID: 4183817 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]